444 MHC-I skewing in mutant calreticulin-positive myeloproliferative neoplasms is countered by heteroclitic peptide cancer vaccination
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Langue: | English |
Publié: |
BMJ Publishing Group
2020-11-01
|
Collection: | Journal for ImmunoTherapy of Cancer |